Skip to main content

Wezlana News

FDA Approves Wezlana for Multiple Inflammatory Diseases

THURSDAY, Nov. 2, 2023 – The U.S. Food and Drug Administration has approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory...

FDA Approves Wezlana (ustekinumab-auub), an Interchangeable Biosimilar to Stelara

October 31, 2023 – Today, the U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Crohn's Disease, Psoriasis, Plaque Psoriasis, Psoriatic Arthritis, Ulcerative Colitis

Wezlana patient information at Drugs.com